Frontal Cortex Neuropathology in Dementia Pugilistica
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Dementia pugilistica (DP) is associated with chronic traumatic brain injury (CTBI), and leads to a “punch drunk” syndrome characterized by impairments in memory and executive function, behavioral changes, and motor signs. Microscopic features include the accumulation of neurofibrillary tangles (NFTs), beta-amyloid (Aβ), and TAR DNA binding protein 43 (TDP-43) pathology. Here we describe detailed clinical and neuropathological data about a 55-year-old retired boxer (ApoE3/4), who presented with executive dysfunction and behavioral impairments. At autopsy, significant Aβ pathology was seen, primarily in the form of diffuse plaques. Tau pathology was extensive and was determined to be of Braak and Braak stage VI. Frontal white matter showed evidence of glial tau inclusions (astrocytes and oligodendroglia). Cerebrovascular pathology was minimal with patchy amyloid angiopathy. Inflammation was another key feature, including microglial activation and significant C1q labeling of neurons, along with NFTs. TDP-43-positive pathology was also observed. Inflammation may be a key inciting as well as propagating feature of DP neuropathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury
McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., Santini, V. E., Lee, H.-S., Kubilus, C. A., & Stern, R. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9d503 · Cited by 2,295 · cited 9×
“, 2010), the clinical presentation appears to be due to a slowly-progressive tauopathy (McKee et al., 2009).”
InfluentialLi, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722 · cited 2×
“For example, neuropathological changes in Parkinson’s disease (PD) progress slowly and spread according to a characteristic pattern (Kordower et al., 2008,2011; Li et al., 2008).”
The role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272 · cited 3×
“Microglial cell activation may result in the release of proinflammatory cytokines and chemokines and exacerbate neuronal dysfunction (Lucas et al., 2006; Nguyen et al., 2002).”
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Frost, B., Jacks, R. L., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808759200 · Cited by 1,252 · cited 2×
“A prime candidate for the spread of tau pathology in CTE is via a transcellular or prion-like mechanism (Aguzzi and Ra-jendran, 2009; Clavaguera et al., 2009; Frost and Diamond, 2010; Frost et al., 2009; Goedert et al., 2010).”
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110
Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998 · cited 1×
“Using a battery of markers representing different phosphorylation states of tau that may indicate disease progression (Augustinack et al., 2002), we observed differences in the distribution and extent of different phosphorylated tau species compared to the other cases (Fig.”
Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host
Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A. L., et al. (2006) · Science · doi:10.1126/science.1131864 · Cited by 971 · cited 2×
“…classical prion disorders, there is some evidence that the source of the nucleating agent and the host can affect the onset and type of neuropathology (Meyer-Luehmann et al., 2006), and that soluble prionoid forms can also induce amyloidogenesis in the CNS (Langer 1066 SAING ET AL. et al., 2011).”
Corsellis, J. A. N., Bruton, C. J., & Freeman-Browne, D. (1973) · Psychological Medicine · doi:10.1017/s0033291700049588 · Cited by 836 · cited 9×
“Often there is scarring of the cerebellum and pronounced Purkinje cell loss (Corsellis et al., 1973).”
InfluentialCaspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Prion-like mechanisms in neurodegenerative diseases
Frost, B., & Diamond, M. I. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2786 · Cited by 776 · cited 4×
“A prime candidate for the spread of tau pathology in CTE is via a transcellular or prion-like mechanism (Aguzzi and Ra-jendran, 2009; Clavaguera et al., 2009; Frost and Diamond, 2010; Frost et al., 2009; Goedert et al., 2010).”
InfluentialGavett, B. E., Stern, R. A., & McKee, A. C. (2011) · Clinics in Sports Medicine · doi:10.1016/j.csm.2010.09.007 · Cited by 696
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543 · cited 5×
“…A b -positive extracellular NFTs. Caspase activation detected as caspase-cleaved fragments of tau (tau-CCP) may suggest that activation of apoptosis pathways may mediate cell death in DP, as has been reported for other tauopathies (Gamblin et al., 2003; Newman et al., 2005; Rissman et al., 2004).”
InfluentialCaspase activation precedes and leads to tangles
de Calignon, A., Fox, L. M., Pitstick, R., Carlson, G. A., Bacskai, B. J., Spires-Jones, T. L., & Hyman, B. T. (2010) · Nature · doi:10.1038/nature08890 · Cited by 517
Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404
Otvos, L., Feiner, L., Lang, E., Szendrei, G. I., Goedert, M., & Lee, V. M. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390607 · Cited by 488 · cited 2×
“Ser396/Ser404 (Otvos et al., 1994), with immunostaining prominent in layer 2 in the DP case, compared to the AD cases (Newman et al.”
The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids
Aguzzi, A., & Rajendran, L. (2009) · Neuron · doi:10.1016/j.neuron.2009.12.016 · Cited by 473
Uryu, K., Laurer, H., McIntosh, T., Praticò, D., Martinez, D., Leight, S., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00446.2002 · Cited by 337
Jiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330
Neuronal cytoskeletal changes are an early consequence of repetitive head injury
Geddes, J. F., Vowles, G. H., Nicoll, J. A. R., & Révész, T. (1999) · Acta Neuropathologica · doi:10.1007/s004010051066 · Cited by 323
Chronic traumatic brain injury associated with boxing
Jordan, B. D. (2000) · Seminars in Neurology · doi:10.1055/s-2000-9826 · Cited by 262 · cited 3×
“We tested whether significant cerebrovascular damage would be present in our patient given previous reports in younger boxers and in TBI patients ( Jordan, 2000).”
Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid Deposition
Langer, F., Eisele, Y. S., Fritschi, S. K., Staufenbiel, M., Walker, L. C., & Jucker, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3088-11.2011 · Cited by 237
Schmidt, M., Zhukareva, V., Newell, K., Lee, V., & Trojanowski, J. (2001) · Acta Neuropathologica · doi:10.1007/s004010000330 · Cited by 230 · cited 5×
“Another relatively consistent feature of DP is the presence of extracellular NFTs, with some studies showing Ab-positive extracellular NFTs (Allsop et al., 1990; Hof et al., 1992; Schmidt et al., 2001; Tokuda et al., 1991).”
InfluentialLocalization and Cell Association of C1q in Alzheimer's Disease Brain
Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W., & Tenner, A. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0043 · Cited by 224
Self-citationHof, P. R., Bouras, C., Bu�e, L., Delacourte, A., Perl, D. P., & Morrison, J. H. (1992) · Acta Neuropathologica · doi:10.1007/bf00304630 · Cited by 213
Matser, J. T., Kessels, A. G. H., Lezak, M. D., & Troost, J. (2001) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.23.6.770.1029 · Cited by 188
In vivo detection of microglial activation in frontotemporal dementia
Cagnin, A., Rossor, M., Sampson, E. L., MacKinnon, T., & Banati, R. B. (2004) · Annals of Neurology · doi:10.1002/ana.20332 · Cited by 187 · cited 2×
“Similar microglial activation has been described in FTLD, both by in vivo imaging (Cagnin et al., 2004), and by immunohistochemistry (Arnold et al.”
DeKosky, S. T., Abrahamson, E. E., Ciallella, J. R., Paljug, W. R., Wisniewski, S. R., Clark, R. S. B., & Ikonomovic, M. D. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.541 · Cited by 152 · cited 2×
“, 1995), and of traumatic brain injury (DeKosky et al., 2007), and we observed ApoE labeling within extracellular NFTs in the DP case (Fig.”
Yoshiyama, Y., Uryu, K., Higuchi, M., Longhi, L., Hoover, R., Fujimoto, S., McIntosh, T., Lee, V. M.-Y., & Trojanowski, J. Q. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.1134 · Cited by 133 · cited 1×
“Interestingly, no motor impairments were observed, which may be due to a lack of NFT pathology, which contrasts with a report in a tauopathy mouse model (Yoshiyama et al., 2005).”
Abrahamson, E. E., Ikonomovic, M. D., Ciallella, J. R., Hope, C. E., Paljug, W. R., Isanski, B. A., Flood, D. G., Clark, R. S. B., & DeKosky, S. T. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.011 · Cited by 90
Quantitative neurohistological features of frontotemporal degeneration
Arnold, S. E., Han, L.-Y., Clark, C. M., Grossman, M., & Trojanowski, J. Q. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00173-1 · Cited by 82 · cited 2×
“, 2004), and by immunohistochemistry (Arnold et al., 2000; Schofield et al., 2003).”
Thal, D. R., Capetillo-Zarate, E., Schultz, C., Rüb, U., Saido, T. C., Yamaguchi, H., Haass, C., Griffin, W. S. T., Del Tredici, K., Braak, H., et al. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1053-1 · Cited by 50 · cited 1×
“In the AD cases, ApoE was found within intracellular NFTs and in association with plaques, as reported previously (Thal et al., 2005).”
Cited by
The spectrum of disease in chronic traumatic encephalopathy
McKee, A. C., Stein, T. D., Nowinski, C. J., Stern, R. A., Daneshvar, D. H., Alvarez, V. E., Lee, H.-S., Hall, G., Wojtowicz, S. M., Baugh, C. M., et al. (2013) · Brain · doi:10.1093/brain/aws307 · Cited by 2,098
The far-reaching scope of neuroinflammation after traumatic brain injury
Simon, D. W., McGeachy, M. J., Bayır, H., Clark, R. S. B., Loane, D. J., & Kochanek, P. M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.13 · Cited by 1,190
Chronic neuropathologies of single and repetitive TBI: substrates of dementia?
Smith, D. H., Johnson, V. E., & Stewart, W. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.29 · Cited by 699
Risk factors for Alzheimer’s disease
A. Armstrong, R. (2019) · Folia Neuropathologica · doi:10.5114/fn.2019.85929 · Cited by 606
Mouzon, B. C., Bachmeier, C., Ferro, A., Ojo, J., Crynen, G., Acker, C. M., Davies, P., Mullan, M., Stewart, W., & Crawford, F. (2014) · Annals of Neurology · doi:10.1002/ana.24064 · Cited by 330
Metadata
- Authors
- Saing, T., Dick, M., Nelson, P. T., Kim, R. C., Cribbs, D. H., & Head, E.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2012-04
- Volume
- 29
- Issue
- 6
- Pages
- 1054-1070
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W2108731817
- Cited by
- 90
- References
- 33
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.